Delivery Order SPE2DB20D1047-SPE2DB25FF41M

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,018.30 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of September 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $29,048.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a performance period through December 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,529.38 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,983.84 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a $5,268.40 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,285,746 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $9,764.34 and a period of performance through November 28, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,154.47 firm-fixed-price delivery order is for the supply of 4,566,178,920 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $5,128.36 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the medical product "MONOVISC 88 MG/4 ML SYRINGE 4ML" and has a completion date of September 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, holding several Indefinite Delivery Contracts (IDCs) with agencies like the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,505.23 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract has an ultimate completion date of October 23, 2023 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,209.52 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF41M
    Delivery Order

This is a $18,756.29 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through February 6, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/7/25, 9:45 AM